Amylyx Pharmaceuticals

Amylyx, a biotechnology company based in Cambridge, Massachusetts, is focused on developing treatments for neurodegenerative diseases. The company's mission is to discover and develop therapies that can help support and create more meaningful moments for those living with conditions like amyotrophic lateral sclerosis (ALS), Alzheimer's disease, progressive supranuclear palsy, and Wolfram syndrome.